Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06130540
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2023-11-08
Brief Title:
Study to Evaluate the Pharmacokinetics Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-25
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-08
First Submit QC Date:
November 8 2023
Study First Post Date:
2023-11-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-02
Last Update Post Date:
2024-07-05
Last Update Post Date Type:
ACTUAL